Category TECHNOLOGY

Yangi

Yangi Brings Cellera® Dry-Forming Technology to U.S. Converters Amid Tariff Changes

As Tariffs Reshape the Molded Fiber Market, Yangi Brings Its Dry-Forming Technology Cellera® to U.S. Converters Yangi, the Swedish developer of Cellera®, a dry-forming technology for fiber-based packaging, is entering the U.S. market with its quick-serve packaging range, as part of…

Read MoreYangi Brings Cellera® Dry-Forming Technology to U.S. Converters Amid Tariff Changes
Maxis

Maxis AI Launches First Verticalized Context Layer to Enable Reliable, Cost-Efficient, and Compliant AI for Life Sciences

Maxis AI Introduces the First Verticalized Context Layer for Life Sciences, a Governed Execution Fabric That Makes Enterprise AI Reliable, Cost-Efficient, and Regulatory Compliant Maxis AI  introduced MaxisAI Holarchy, its Verticalized Context Layer, a governed institutional memory that gives life sciences…

Read MoreMaxis AI Launches First Verticalized Context Layer to Enable Reliable, Cost-Efficient, and Compliant AI for Life Sciences
American

American Chemical Society Honors Syngenta’s Camilla Corsi With 2026 International Award for Agrochemical Research

American Chemical Society Names Syngenta’s Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals Camilla Corsi, Head of Crop Protection Research & Development at Syngenta, is the winner of the prestigious 2026 American Chemical Society (ACS)…

Read MoreAmerican Chemical Society Honors Syngenta’s Camilla Corsi With 2026 International Award for Agrochemical Research
Lōkahi Therapeutics’ ai² Futures Lab™

Lōkahi Therapeutics’ ai² Futures Lab™ Transforms Biopharma Pipeline Development

Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline Glucotrack announced the continued expansion of the ai² Futures Lab™ operated through its wholly owned subsidiary, Lōkahi Therapeutics™ Inc. During its first year, the ai² Futures Lab™ identified more than 45…

Read MoreLōkahi Therapeutics’ ai² Futures Lab™ Transforms Biopharma Pipeline Development
Thermo Fisher Scientific

Thermo Fisher Scientific Highlights End-to-End Lab and Diagnostic Innovations at ADLM 2026

Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026 Thermo Fisher Scientific, the world leader in serving science, will showcase its latest diagnostic innovations, recent regulatory milestones and expanded capabilities at the Association…

Read MoreThermo Fisher Scientific Highlights End-to-End Lab and Diagnostic Innovations at ADLM 2026
Wiley

Wiley Joins DOE’s Genesis Mission Consortium to Accelerate AI-Driven Scientific Innovation

Wiley Joins U.S. Department of Energy’s Genesis Mission Consortium to Advance AI-Powered Scientific Discovery Wiley announced its membership in the Genesis Mission Consortium, the public-private partnership supporting the U.S. Department of Energy’s (DOE) Genesis Mission, joining organizations including Nvidia, AWS,…

Read MoreWiley Joins DOE’s Genesis Mission Consortium to Accelerate AI-Driven Scientific Innovation
illumiSonics

illumiSonics and Sunnybrook Launch Laser Histology Trial for Mohs Surgery

illumiSonics and Sunnybrook Launch INOVAIT Focus Fund–Backed Clinical Trial Bringing Label-Free Laser Histology to Mohs Skin Cancer Surgery illumiSonics Inc., a medical technology company commercializing label-free tissue imaging, announced the launch of a prospective clinical validation study at Sunnybrook Health…

Read MoreillumiSonics and Sunnybrook Launch Laser Histology Trial for Mohs Surgery
ZEISS-Meditec-Chooses-Nirrin-Technologies

ZEISS Meditec Chooses Nirrin Technologies’ Atlas® System to Modernize Hyaluronic Acid Manufacturing

ZEISS Meditec Selects Atlas® System from Nirrin Technologies to Modernize Hyaluronic Acid Manufacturing Workflows Nirrin Technologies, a developer of analytical tools designed to transform bioprocess analytics, announced that Hyaltech, a Carl ZEISS Meditec (CZM) company has purchased an Atlas® system to support…

Read MoreZEISS Meditec Chooses Nirrin Technologies’ Atlas® System to Modernize Hyaluronic Acid Manufacturing
OrsoBio

OrsoBio to Present Mitochondrial Protonophore Data at ADA 2026

OrsoBio to Present Preclinical and Clinical Data from its Mitochondrial Protonophore Portfolio at the American Diabetes Association’s 2026 Scientific Sessions OrsoBio, Inc. a clinical-stage biopharmaceutical company developing treatments for obesity and related metabolic disorders, announced new clinical and preclinical data…

Read MoreOrsoBio to Present Mitochondrial Protonophore Data at ADA 2026
CicadaBio to Present CC-18 Muscle-Preserving

CicadaBio to Present CC-18 Muscle-Preserving Weight Loss Candidate at ADA 2026

CicadaBio Announces Oral Presentation on CC-18, a First-in-Class GLP-1/ActRII Fusion Protein Designed for Muscle-Preservation Weight Loss, at ADA 2026 CicadaBio announced that new preclinical data for CC-18, its investigational GLP-1/anti-ActRII dual-pathway fusion protein, were shared during an oral presentation at…

Read MoreCicadaBio to Present CC-18 Muscle-Preserving Weight Loss Candidate at ADA 2026